here are 2 types of pneumoccocal vaccine:
Pneumococcal Conjugate Vaccine:
Pneumococcal Conjugate Vaccine:*(PCV13 or Prevnar13®)“Pfizer” Synflorix® “GSK”.
This vaccine is in the obligatory vaccination schedule in most countries but not in Egypt.
In Egypt it is one of highly recommended vaccines outside the schedule.
CDC recommends vaccination with the pneumococcal conjugate vaccine for:
All children younger than 2 years old.
All adults 65 years or older
People 2 through 64 years old with certain medical conditions:
☆Children:
Who have certain illnesses (sickle cell disease, HIV infection, diabetes, immune compromising conditions, nephrotic syndrome, or chronic heart, lung, kidney, or liver disease)
With cochlear implants or cerebrospinal fluid (CSF) leaks (escape of the fluid that surrounds the brain and spinal cord)
☆Adults:
With chronic illnesses.
With conditions that weaken the immune system.
Smokers (19-64 years old).
Prevnar ®: is given to:
children at 2, 4, 6, and 12 through 15 months old.
Adults who need this vaccine only get a single dose.
Children who miss their shots or start the series later should still get the vaccine. The number of doses recommended and the intervals between doses will depend on the child’s age when vaccination begins.
Prevenar is administered intramusculary.
The vaccine helps protect against the 13 types of pneumococcal bacteria that most commonly cause serious infections in children and adults.
It can also help prevent ear infections and pneumonia caused by those 13 types of pneumococcal bacteria.
the pneumococcal polysaccharide
--------------------- vaccine
*(PPSV23 or Pneumovax23®) “Merck”.
for:
All adults 65 years or older
People 2 through 64 years old with certain medical conditions.
Adults 19 through 64 years old who smoke cigarettes.
It is not licensed for use in children aged <2 years.
Pneumovax23®:
given as a single dose to people who need it.
CDC recommends one or two additional doses for people with certain chronic medical conditions.
PPSV23 may be administered either intramuscularly or subcutaneously.
This vaccine helps protect against serious infections caused by 23 types of pneumococcal bacteria.
Contraindications of pneumococcal vaccines:
not given to a child or teen who has experienced a serious reaction (e.g., anaphylaxis) to a prior dose of the vaccine or to any of its components.
PCV13 is not given to people wih previous allergic reaction to any vaccine containing diphtheria toxoid (for example, DTaP).